Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Pyrophosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrophosphoric Acid SCHEMBL28407584 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL28409467 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL593766 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL249808 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL221629 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL10830790 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL160240 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL3465536 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL22749765 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA | |
| Pyrophosphoric Acid SCHEMBL3968384 | 0.96 | LMNA (0.35) | CA1CA4CA5ACA5BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4633895-A1 | PLASTIC SUBSTRATE & METHOD OF REMOVING A MARK OR IMAGE THEREFROM | DataLase Ltd. (GB) | 2025-10-22 | — | — | EP | disclosed |
| US-12285961-B2 | Heat transfer agents in an image-forming composition | DATALASE LTD. (GB) | 2025-04-29 | — | — | US | disclosed |
| WO-2024127011-A1 | PLASTIC SUBSTRATE & METHOD OF REMOVING A MARK OR IMAGE THEREFROM | DATALASE LTD. (GB) | 2024-06-20 | — | — | WO | disclosed |
| US-20230037133-A1 | A COMPOSITION | DATALASE LTD. (GB) | 2023-02-02 | — | — | US | disclosed |
| EP-4072863-A1 | A COMPOSITION | DataLase Ltd (GB) | 2022-10-19 | — | — | EP | disclosed |
| WO-2021116702-A1 | A COMPOSITION | DATALASE LTD. (GB) | 2021-06-17 | — | — | WO | disclosed |
| EP-2250251-B1 | IMPROVED CULTURE MEDIA ADDITIVE AND PROCESS FOR USING IT | SARTORIUS STEDIM CELLCA GMBH (DE) | 2017-11-22 | — | — | EP | disclosed |
| US-8637312-B2 | Mammalian culture media with polyamine and iron | CELLCA GMBH (DE) | 2014-01-28 | — | — | US | disclosed |
| EP-2250251-A1 | IMPROVED CULTURE MEDIA ADDITIVE AND PROCESS FOR USING IT | Cellca GmbH (DE) | 2010-11-17 | — | — | EP | disclosed |
| US-20100285533-A1 | CULTURE MEDIA ADDITIVE AND PROCESS FOR USING IT | SARTORIUS STEDIM CELLCA GMBH (DE) | 2010-11-11 | — | — | US | disclosed |
| WO-2009087087-A1 | IMPROVED CULTURE MEDIA ADDITIVE AND PROCESS FOR USING IT | CELLCA GMBH (DE) | 2009-07-16 | — | — | WO | disclosed |
| US-20070118000-A1 | Preparation and use of iminodisuccinic acid ammonium metal salts | LANXESS DEUTSCHLAND GMBH (DE) | 2007-05-24 | — | — | US | disclosed |
| US-7183429-B2 | Preparation and use of iminodisuccinic acid ammonium metal salts | LANXESS DEUTSCHLAND GMBH (DE) | 2007-02-27 | — | — | US | disclosed |
| US-20030220522-A1 | Preparation and use of iminodisuccinic acid ammonium metal salts | LANXESS DEUTSCHLAND GMBH (DE) | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070118000-A1 | Preparation and use of iminodisuccinic acid ammonium metal salts | ME3, ME2, ME1 | CA1 51/4885CA4 37/4885CA5A 24/4885 |
| US-20030220522-A1 | Preparation and use of iminodisuccinic acid ammonium metal salts | ME3, ME2, ME1 | CA1 56/4885CA4 28/4885CA5A 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.